Relay Therapeutics GAAP EPS of -$0.43 misses by $0.02

* Relay Therapeutics press release [https://seekingalpha.com/pr/20297824-relay-therapeutics-reports-third-quarter-2025-financial-results-and-corporate-updates] (RLAY [https://seekingalpha.com/symbol/RLAY]): Q3 GAAP EPS of -$0.43 misses by $0.02.

MORE ON RELAY THERAPEUTICS

* Relay Therapeutics Is A Buy For Its Superb Safety Data [https://seekingalpha.com/article/4833194-relay-therapeutics-is-a-buy-for-its-superb-safety-data]
* Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) [https://seekingalpha.com/article/4821663-relay-therapeutics-inc-rlay-presents-at-morgan-stanley-23rd-annual-global-healthcare]
* Relay Therapeutics Q3 2025 Earnings Preview [https://seekingalpha.com/news/4516172-relay-therapeutics-q3-2025-earnings-preview]
* Goldman's 48 potential M&A candidates [https://seekingalpha.com/news/4499689-goldmans-48-potential-ma-candidates]
* Seeking Alpha’s Quant Rating on Relay Therapeutics [https://seekingalpha.com/symbol/RLAY/ratings/quant-ratings]